Aktivax Pharma is shutting most operations, closing two out of three facilities and laying off 70 employees due to what the drug auto-injectable manufacturer refers to as “unexpected circumstances.”
“Unfortunately, some of our planning assumptions were not realized and we had to curtail our scale-up plans for the time being, which has led us to reduce our workforce until conditions change,” CEO Amir Genosar said in a statement to Endpoints News.
Amir Genosar Layoffs by the Government-funded company will be spread across three sites in Colorado. Its headquarters at Broomfield and one of two sites at Fort Collins will close, as per a company letter to the state’s WARN Act coordinator. Affected roles include engineers, technicians and directors. The first staff separation occurred on Aug. 25.
Aktivax will continue to operate as a CDMO and is working on advanced packaging…
Click here to view original post
